Hemispherx BioPharma (HEB)

[robtcohen]

"Hemispherx has in excess of 100 patents comprising its core intellectual property estate covering various forms of double stranded (ds) RNA and their fields of therapeutic application, a fully commercialized product (Alferon N) and a GMP certified manufacturing facilities for its novel pharma products in New Brunswick, New Jersey." http://www.hemispherx.net/content/rnd/drug_candidates.htm

comment:

This means there is life still in the ole stock. There have been setbacks, because it's a competitive, cut-throat jungle in pharma & biotech phenomena.

I only have 2000 shares, and there have been price fluctuations, while I'm even now, and since it's about my patience/luck/intuition/ignorance/random/blind speculation, and the darn stock has not been a loss, I'm going to continue holding and perhaps buying some more.

I won't post it as prettier/uglier than it is.

With over 100 patents, I would think its book value plus all its experiences would be an attraction to potential partners & buyers.

So, Mr. Icahn's researcher, if you're seeing this semi terrific posting, then please tell Carl about this patent haystack.